1. Wnt Antagonist as therapeutic targets in Ovarian Cancer
   Y Krithicaa Narayanaa et al, 2022, The International Journal of Biochemistry & Cell Biology CrossRef
2. CircWHSC1 expedites cervical cancer progression via miR-532-3p/LTBP2 axis
   Yan Li et al, 2022, Mol Cell Biochem CrossRef
3. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients
   Mingjie Yuan et al, 2022, Front. Genet. CrossRef
4. Circular RNAs play roles in regulatory networks of cell signaling pathways in human cancers
   Mansour Almouh et al, 2022, Life Sciences CrossRef
5. Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed
   Xiaoyi Hu et al, 2022, Front. Immunol. CrossRef
6. The mechanism of lncRNAs in the crosstalk between epithelial-mesenchymal transition and tumor microenvironment for early colon adenocarcinoma based on molecular subtyping
   Hanlin Liang et al, 2022, Front. Genet. CrossRef
7. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
   Mehrdad Hashemi et al, 2022, Pharmacological Research CrossRef
8. An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
   Gen Li et al, 2022, Front. Genet. CrossRef
9. Regulatory Role of Fatty Acid Metabolism-Related Long Noncoding RNA in Prostate Cancer: A Computational Biology Study Analysis
   Yutao Wang et al, 2023, Journal of Oncology CrossRef
10. The role of pyroptosis-related lncRNA risk signature in ovarian cancer prognosis and immune system
    Yanling Wu et al, 2023, Discov Onc CrossRef
11. Establishment of a placental lncRNA-mRNA expression network for early-onset preeclampsia
    Ya Chen et al, 2024, BMC Pregnancy Childbirth CrossRef
12. MicroRNA-532 as a probable diagnostic and therapeutic marker in cancer patients
    Malihe Lotfi et al, 2024, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis CrossRef
13. LINC01094: A Key Long Non-Coding RNA in the Regulation of Cancer Progression and Therapeutic Targets
    Qiang Yi et al, 2024, Heliyon CrossRef
14. LINC01094 promotes gastric cancer through dual targeting of CDKN1A by directly binding RBMS2 and HDAC1
    Xinyi Zhou et al, 2024, Biol Direct CrossRef